• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Insurers Dodged Billions in Rebate Payments

Article

If the Affordable Care Act's requirement that insurers spend at least 80% on patient care had come into effect a year early, policyholders would have received about $2 billion in rebates from insurance companies, according to a new report from the Commonwealth Fund.

The medical loss ratio (MLR) provision of the Affordable Care Act (ACA) mandates that starting in 2011, insurers covering large groups must spend at least 85 cents per dollar of revenue on medical care or "activities that improve healthcare quality." For small group and individual plans, they must spend 80 cents per dollar.

Read the full story: http://hcp.lv/HZpgJW

Source: MedPage Today

Related Videos
Eric Levin, Scripta
Margaret Krackeler, MD
Margaret Krackeler, MD
Margaret Krackeler, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Related Content
pill with water -New Africa - stock.adobe.com

5 Things to Know About the Oral GLP-1 Era

February 6th 2026
Article

Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist.

Read More

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

January 1st 2026
Podcast

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

Debates at the International Stroke Conference 2026 centered on optimal treatment of ischemic stroke in the modern era. | Image credit: Aliaksandr Marko - stock.adobe.com

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

February 6th 2026
Article

In a pair of lively debates at the International Stroke Conference 2026, experts from around the world discussed controversies in stroke care.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

Inotuzumab-ozogamicin | Image Credit: © molekuul.be-stock.adobe.com

Inotuzumab Ozogamicin Outcomes in ALL Validated Outside of Clinical Trials

February 4th 2026
Article

Real-world inotuzumab ozogamicin boosts remission in relapsed/refractory B-cell ALL, supports transplant, and flags sinusoidal obstruction syndrome risk.

Read More

Jesse Dresser, Esq

New Regulations on PBMs Become Law: What This Means for Pharmacies Nationwide—A Q&A With Jesse Dresser, Esq

February 4th 2026
Article

The Consolidated Appropriations Act of 2026 features new language that could change the way that pharmacy benefit managers (PBMs) operate in the US.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.